Glenview Capital Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Glenview Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $16.5 Million - $17.5 Million	-1,013,402 Reduced 11.12%	8,102,119 $133 Million
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $116 Million - $130 Million	-6,988,701 Reduced 43.4%	9,115,521 $153 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $14.1 Million - $16.8 Million	843,710 Added 5.53%	16,104,222 $294 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $23.5 Million - $29 Million	-1,528,077 Reduced 9.1%	15,260,512 $278 Million
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $10.1 Million - $11.4 Million	593,279 Added 3.66%	16,788,589 $300 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $54.9 Million - $73.4 Million	-3,761,689 Reduced 18.85%	16,195,310 $290 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $138 Million - $216 Million	-10,625,722 Reduced 34.74%	19,956,999 $303 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $53 Million - $65.4 Million	3,138,875 Added 11.44%	30,582,721 $603 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $16.4 Million - $18.2 Million	1,013,018 Added 3.83%	27,443,846 $472 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $5.28 Million - $6.52 Million	318,168 Added 1.22%	26,430,828 $468 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $436 Million - $562 Million	26,112,660 New	26,112,660 $532 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Glenview Capital Management, LLC with notifications on news.